Build, Buy or Enable

Build it yourself or buy someone who already has it. That is the choice most owners are handed. It leaves out the path that quietly does the most — enabling something the whole market can use and earning a place in it by helping to build it.

The build-versus-buy question is old and familiar. Do you commit the years and the capital to build a capability from scratch, or do you pay a premium to acquire someone who already runs it? Both answers can be right. Both also share a blind spot: they treat the capability as something one company owns and controls, when the most valuable capabilities are the ones many companies come to depend on.

There are two further paths, and together they are what this firm is built around: enable and perform. An enabler does not simply build for itself or buy to absorb. It builds shared infrastructure — the standards, the connections, the rails — that other players travel on to reach outcomes none of them could reach alone. A performer goes one step further and stands on the road it helped open, accountable for a measured result. Both are closer to a mentor than a competitor: they make the people around them better and take their return from the health of the whole route rather than from any single toll.

The four paths, honestly

The distinction matters because the four paths carry very different risk, cost and reach. Naming them plainly is the first step. Read the grid on its diagonals: the two owner-centred paths — Build and Buy — sit corner to corner, and the two market-centred paths — Enable and Perform — sit on the other diagonal.

The B's run one diagonal (Build, Buy); Enable and Perform run the other. One diagonal asks “how do I get this capability?” The other asks “how does this capability get built once, proven, and used by many?”

Build and buy both answer the question “how do I get this capability?” Enable and perform answer a larger one: “how does this capability get built once, well, proven in the open, so that many can use it?” That reframing is where the durable value sits, because the winner is no longer a single company — it is the route itself, and the party the market trusts to keep it honest.

You do not have to own the whole road to profit from it. You have to help build the highway everyone needs.

Business highways, not private roads

Picture the difference between a private driveway and a highway. A driveway serves one house. A highway serves a region — and the people who planned it well, laid it straight and connected it to the places that mattered capture value every time someone uses it. Value-based business highways are the same idea applied to a market: shared rails that let many operators, buyers and capital move faster, safer and cheaper toward better outcomes.

A private road is a build-or-buy asset — it belongs to one owner and its value stops at the property line. A business highway is an enablement asset. It is deliberately designed so that many can travel it, and it is worth more precisely because they do. The enabler's advantage is not exclusivity; it is that the route was built to be used, and it was built by someone the market trusts to keep it open and fair.

This is why enablement is not charity and not a giveaway. The highway earns. It earns from volume rather than from a single toll, from the standards it sets, and from the trusted position of the party that built it. Done right, an enabler can build something of lasting value while still being the most useful player on the road.

Why the market adopts what you help build

Here is the part that build and buy can never reach. Markets do not adopt a highway because a vendor announces it. They adopt it because the people who will travel it helped design it, because someone they trust already has skin in the road, and because the enabler is a contributor rather than a spectator collecting rent.

Adoption is earned by contribution. When the enabler has helped build the thing — shared the risk, done the unglamorous work, stayed accountable to how the route actually performs — acceptance follows naturally. The market trusts a builder who is on the road with them far more than a seller standing beside it. That trust is the real moat: not a patent or a price, but a reputation for having contributed to something the whole market now depends on.

The real problem is alignment, not capability

State the problem plainly. The reason good capabilities stall is rarely that they do not work. It is that they are aligned to the wrong balance sheet. Build and buy both bind a capability to a single owner: the owner carries the cost, the owner captures the toll and, quite reasonably, everyone else on the market treats it as somebody else's asset to be resisted, re-priced or routed around. Misaligned incentives are the actual blocker — not technology, not talent and not capital.

So the solution is not a better product; it is better alignment. Enable puts the capability on shared rails so its value grows as the market uses it, and perform welds the enabler's own pay to the outcomes the market actually cares about. The moment your return rises only when the market's results rise, resistance turns into pull. Buyers stop asking “what are you selling me?” and start asking “how do we get you on our side of the table?” That is market alignment: the problem was whose interests the capability served, and the answer is to serve the market's and get paid for doing so.

Capability is not the constraint. Alignment is. Fix whose outcomes you are paid on, and adoption stops being a fight.

When it becomes scalable

Enablement and performance are not automatically scalable — done wrong they are just expensive custom work. They scale only when three conditions hold together, and it is worth being honest about each.

• The route is standardised. The rails, definitions and hand-offs are common enough that a new participant plugs in rather than commissioning a bespoke build. Standardisation is what turns a private road into a highway.
• Performance is measured and portable. The outcome you are paid on is defined the same way for everyone and provable in the open. A result that travels from one participant to the next is what lets the model repeat instead of being re-argued each time.
• Marginal cost per participant falls. Each additional traveller costs less to add than the last, so reach compounds while unit economics improve rather than erode.

When those three line up, the model tips from linear to scalable: every proven result lowers the cost of winning the next participant, and every new participant makes the route more valuable to the rest. Until they line up, the disciplined move is to stay deliberately small — one route, one measured outcome, one reference relationship — and earn the proof first. Scale is a reward for alignment that has been demonstrated, not a launch strategy.

So the choice is not only build or buy. The more powerful question is whether you can enable and perform — build the value-based highways your market needs, stand on them accountable for a measured result, earn adoption by contributing to the build and take your return from the health of the whole route. That is the path this firm is built to walk with owners: deep enough to contribute for real, aligned enough to be paid on outcomes and trusted enough that when the highway opens, the market is already on it.

Northview Health Partners works with healthcare business owners, operators and their advisors across the ownership lifecycle. This article is educational and is not an offer, solicitation or legal, tax or investment advice. Outcomes depend on the specific facts, the parties involved and definitive documentation, reviewed by qualified counsel and advisors.